| Dr Jane Ellen Lacefield, PHARMD | |
|
1308 Ashley Circle, Bowling Green, KY 42104 | |
| (270) 781-5661 | |
| Not Available |
| Full Name | Dr Jane Ellen Lacefield |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1308 Ashley Circle, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316563075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 011381 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jane Ellen Lacefield, PHARMD 1308 Ashley Circle, Bowling Green, KY 42104 Ph: (270) 781-5661 | Dr Jane Ellen Lacefield, PHARMD 1308 Ashley Circle, Bowling Green, KY 42104 Ph: (270) 781-5661 |
News Archive
Unilife Corporation wishes to advise that its Form S-1 Resale Registration Statement has now been declared effective by the United States Securities and Exchange Commission ("SEC"). As previously advised, the Registration Statement simply removes restrictions which apply under US federal securities laws to the sale of shares underlying certain options previously issued by the Company.
Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Teenage exploration and risk taking could be explained by dramatic changes in the brain that allow elaborate planning and are driven by the need for immediate reward, according to a University of Pittsburgh neuroscientist who will be talking about her research in a panel discussion and press briefing at the American Association for the Advancement of Science annual meeting, Feb. 13 to 16, in San Jose, Calif.
ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that enrolment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464.
› Verified 6 days ago
Kevin Roger Sansom, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2385 Nashville Rd, Bowling Green, KY 42101 Phone: 270-393-8979 | |
Greg S Hines, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1340 Highway 185, Bowling Green, KY 42101 Phone: 270-842-4341 Fax: 270-842-7893 | |
Alaa Tlais, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3028 Hunting Creek Dr, Bowling Green, KY 42104 Phone: 270-320-1320 | |
Lindsey Peden, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4863 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-467-0542 | |
Nicholas Bedwell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 Lovers Ln, Bowling Green, KY 42103 Phone: 270-842-4844 | |
Mrs. Kathy Renee Hardy, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3158 Louisville Road, Bowling Green, KY 42101 Phone: 270-842-6161 Fax: 270-782-7466 | |
Bradley Settle, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2380 Nashville Rd, Bowling Green, KY 42101 Phone: 270-842-6301 |